Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Eton Pharmaceuticals, Inc. (ETON)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
3
| Krempa David (Chief Business Officer) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 04/14/2022 |
3
| Gruber James R. (CFO) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 03/17/2021 |
3
| Adams Jennifer McKie (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 04/06/2020 |
3
| Opaleye Management Inc. (10% Owner) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| Imprimis Pharmaceuticals, Inc. (10% Owner) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| CASAMENTO CHARLES J (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| MAIER PAUL V (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| RIEDEL NORBERT G (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| BAUM MARK L (Director) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| Troutman William Wilson (CFO, Treasurer & Secretary) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
| 11/13/2018 |
3
| BRYNJELSEN SEAN (President & CEO) has filed a Form 3 on Eton Pharmaceuticals, Inc. |
|
|